← Back to Search

Continuous Glucose Monitoring for Diabetes

N/A
Recruiting
Led By Ilias Spanakis, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Veterans with history of DM2 managed with insulin (either basal bolus, basal only or basal with per os DM medications), admitted to the Baltimore VA Medical Center, who have at least 1 risk factor of hypoglycemia
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion-hospitalization (average length of stay at the hospital of 4-6 days)
Awards & highlights

Study Summary

This trial is testing a new system to help manage blood sugar levels for hospitalized patients with diabetes. The system wirelessly transmits sugar levels from the patient's bedside to a monitor at the nursing station. The goal is to decrease hypoglycemia and improve clinical outcomes.

Who is the study for?
This trial is for Veterans with type 2 diabetes managed with insulin, admitted to the Baltimore VA Medical Center, and have at least one risk factor for low blood sugar. It's not for those staying in the hospital less than 3 days, pregnant women, diet-managed diabetics, type 1 diabetics or those on high-dose steroids.Check my eligibility
What is being tested?
The study tests a new Glucose Telemetry System (GTS) that wirelessly sends glucose levels from a patient's bedside to a monitor at the nursing station. The aim is to reduce low blood sugar incidents and improve outcomes in hospitalized diabetic patients.See study design
What are the potential side effects?
Since this trial involves monitoring devices rather than medications, traditional side effects are minimal. However, there may be discomfort or skin irritation where the device attaches to the body.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a veteran with type 2 diabetes managed with insulin, at risk of low blood sugar.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion-hospitalization (average length of stay at the hospital of 4-6 days)
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion-hospitalization (average length of stay at the hospital of 4-6 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decrease in hypoglycemia during the hospitalization

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Intervention group (Continuous Glucose Monitroring and POC)Active Control2 Interventions
Hospitalized patients with DM2 will be monitored with Glucose Telemetry System (GTS) and Point of Care (POC) finger-stick blood glucose levels with application of hypoglycemia prevention protocol (activated based the GTS lower glucose alarms)
Group II: Control group (Point of Care-POC)Placebo Group1 Intervention
Hospitalized patients with DM2 will be monitored with POC blood glucose levels and application of hypoglycemia prevention protocol (activated based the POC values)

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,606 Previous Clinical Trials
3,305,761 Total Patients Enrolled
Ilias Spanakis, MDPrincipal InvestigatorBaltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Media Library

Intervention group (Continuous Glucose Monitroring and POC) Clinical Trial Eligibility Overview. Trial Name: NCT03508934 — N/A
Low Blood Sugar Research Study Groups: Control group (Point of Care-POC), Intervention group (Continuous Glucose Monitroring and POC)
Low Blood Sugar Clinical Trial 2023: Intervention group (Continuous Glucose Monitroring and POC) Highlights & Side Effects. Trial Name: NCT03508934 — N/A
Intervention group (Continuous Glucose Monitroring and POC) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03508934 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for this medical experiment currently available?

"Confirmed, this clinical trial is currently recruiting as per the information posted on clinicaltrials.gov. The initial post date was July 1st 2018 and the most recent update was published on July 19th 2022; they need to find a total of 244 patients across one site."

Answered by AI

How many individuals are presently enrolled in this clinical test?

"Verified. According to clinicaltrials.gov, this medical trial is in the process of recruiting participants since it was first made available on July 1st 2018 and last updated on July 19th 2022. A total of 244 patients need to be enrolled from one single location."

Answered by AI
Recent research and studies
~10 spots leftby Jun 2024